A Food and Drug Administration advisory panel voted 16-2 Friday to advise the agency against approving a booster dose of the Pfizer-BioNTech Covid-19 vaccine.
The vote is non-binding, but it is an unexpected roadblock for the Biden administration's plan to begin administering boosters widely as early as next week. Pfizer is seeking approval from FDA to offer the booster to people 16 and older, while Moderna has applied for authorization to market boosters for people 18 and older.
The advisory panel's unexpected no vote came after an hours-long debate that centered on concerns about the amount and qualify of data available to weigh the booster's long-term effectiveness and its safety in young people.
Fonte: POLITICO
Nenhum comentário:
Postar um comentário